Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Loftus, Peter
doi: 10.1016/j.bbr.2012.09.021 145 HayesMRLeichnerTMZhaoSLeeGSChowanskyAZimmerDet al
Peptides are a topic that's receiving a lot of attention these days, in part because of the excitement about the so-called GLP-1 analogs or agonists
Zhang, H., Hu, J
Both medications are FDA-approved for chronic weight management in adults with obesity or overweight with weight-related health conditions
That magnitude matters because it positions berobenatide as more than weight loss with modest glycemic benefits. It reads like a serious diabetes drug, not just an anti-obesity medication with metabolic side effects
US$ 24.01
US$ 29.37
US$ 29.49
